Latest News for GTHP
Haemonetics (NYSE: HAE - Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Risk and Volatility Haemonetics has a beta of 0.36,
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, provided several updates in conjunction with the Company's 2025 10k financial report, filed on March 30, 2026. First, preliminary analysis of the FDA clinical study data has…
Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price fell 12.7% on Monday. The company traded as low as $0.2620 and last traded at $0.2620. 3,800 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 10,586 shares. The stock had previously closed at $0.30. Guided Therapeutics
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GTHP.
U.S. House Trading
No House trades found for GTHP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.